News
The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...
1h
AllAfrica on MSNStrengthening Lassa Fever Vaccine Research and Trial Capacity in West Africa
In West Africa, Lassa fever remains a persistent and recurring health threat, causing hundreds of lives each year and underscoring urgent need for sustained investment in research and vaccine ...
Researchers are using bioinformatics tools and AI to develop universal vaccines, which could protect against future SARS-CoV-2 variants.
Vaccines aren’t just a good idea for humans — pets and livestock need the protection they provide as well, according to the Michigan Department of Agriculture and Rural Development. Especially in the ...
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.
Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.
National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars’ ...
(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...
The West Virginia Board of Education voted at its monthly meeting Wednesday to send a letter to the Professional Charter ...
( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs,supporting potential for improved protection against infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results